Gregory J Dore - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gregory J Dore

Showing results (401-410 of 404) with videos related to

Pageof 41

Sort By:

You have reached the last page of results.This site can display upto 404 results.

The New England Journal of Medicine|January 25, 2018

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.

JAMA Psychiatry|April 1, 2026

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.

Nature|November 4, 2022

A multinational Delphi consensus to end the COVID-19 public health threatJeffrey V Lazarus, Diana Romero, Christopher J Kopka, et al.

NEJM Evidence|February 6, 2024

A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.

Pageof 41

Search research articles

Showing results (401-410 of 404) with videos related to

Sort By:

Pageof 41

You have reached the last page of results.This site can display upto 404 results.

The New England Journal of Medicine|January 25, 2018

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.

JAMA Psychiatry|April 1, 2026

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.

Nature|November 4, 2022

A multinational Delphi consensus to end the COVID-19 public health threatJeffrey V Lazarus, Diana Romero, Christopher J Kopka, et al.

NEJM Evidence|February 6, 2024

A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.

Pageof 41